These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 10745445)

  • 1. Local arterial drug delivery: a golden gun without bullets?
    Schwartz RS; Lubbe D; Altman J; Holmes DR
    J Invasive Cardiol; 1999 Oct; 11(10):620-1. PubMed ID: 10745445
    [No Abstract]   [Full Text] [Related]  

  • 2. Local drug delivery via transvascular injection.
    Gonschior P; Backfisch G; Muth G; Schiele R; Vogel-Wiens C; Pahl C; Sponer G
    J Invasive Cardiol; 1999 Oct; 11(10):600-7. PubMed ID: 10745441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The acute hemodynamic effects of the new vasodilating beta blocker carvedilol in comparison with combined administration of nifedipine and propranolol in patients with coronary heart disease].
    Mauser M; Voelker W; Ickrath O; Hoffmeister HM; Karsch KR
    Z Kardiol; 1989 Nov; 78(11):726-31. PubMed ID: 2609718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of the drug interaction between carvedilol and dobutamine in inducing of severe hypotension in a case with acute coronary syndrome].
    Vural M
    Anadolu Kardiyol Derg; 2007 Jun; 7(2):229. PubMed ID: 17513236
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined amiodarone and low-dose carvedilol treatment for severe heart failure in childhood.
    Tsuda E; Matsuo M; Sakaguchi H; Hayashi T; Hosoda K; Miyazaki A
    Pediatr Int; 2010 Feb; 52(1):e39-42. PubMed ID: 20158646
    [No Abstract]   [Full Text] [Related]  

  • 6. [Efficacy of ramipril, carvedilol, and trimetazidine MR in improvement of quality of life of patients after myocardial infarction].
    Gafurova RM; Abdullaev AA; Kadieva IA; Islamova UA; Mutalipov KhM
    Kardiologiia; 2010; 50(12):15-8. PubMed ID: 21591386
    [No Abstract]   [Full Text] [Related]  

  • 7. [Neither propranolol nor the vasodilating beta-blocker carvedilol have a direct effect on coronary resistance vessels].
    Sievert H; Schmidt T; Frey G; Schräder R; van der Does R; Kaltenbach M; Kober G
    Z Kardiol; 1991 Jan; 80(1):15-9. PubMed ID: 1674632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of carvedilol therapy on myocardial functional reserve in patients with advanced heart failure caused by nonischemic dilated cardiomyopathy.
    Paraskevaidis IA; Tsiapras D; Karavolias G; Adamopoulos S; Dodouras T; Cokkinos P; Kremastinos DT
    J Am Soc Echocardiogr; 2006 May; 19(5):529-35. PubMed ID: 16644436
    [No Abstract]   [Full Text] [Related]  

  • 9. Major heart failure news from 2001.
    Francis D
    Heart Fail Monit; 2002; 2(4):147-8. PubMed ID: 12638556
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical and hemodynamic effects of anaprilin and carvedilol in patients with coronary heart disease].
    Vasil'ev AP; Strel'tsova NN; Gorbunova TIu; Dubova TV
    Klin Med (Mosk); 2001; 79(12):13-6. PubMed ID: 11840802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A synchronized diastolic microinjecctor. Possibilities of its utilization in acute coronary insufficiency].
    Courbier R; Baille Y; Goudard A; Bourgade P; Henry E
    Agressologie; 1967; 8(2):195-9. PubMed ID: 5602127
    [No Abstract]   [Full Text] [Related]  

  • 12. Carvedilol in heart failure: the MOCHA trial.
    Osterziel KJ
    Circulation; 1997 Oct; 96(8):2742; author reply 2743-4. PubMed ID: 9355927
    [No Abstract]   [Full Text] [Related]  

  • 13. Carvedilol and dose-related improvements in left ventricular function.
    Ghali JK
    Circulation; 1997 Oct; 96(8):2743-4. PubMed ID: 9355928
    [No Abstract]   [Full Text] [Related]  

  • 14. [Beta blockers in heart failure. Experiences and recommendations for clinical use. ANMCO-Area Heart Failure].
    Sinagra G; Boccanelli A; Camerini F; Gavazzi A; Gronda E; Maggioni AP; Opasich C; Rapezzi C; Scherillo M; Tavazzi L
    G Ital Cardiol; 1998 Jan; 28(1):61-70. PubMed ID: 9493048
    [No Abstract]   [Full Text] [Related]  

  • 15. [Implantation of an extracardiac mesh in the treatment of dilated cardiomyopathy: the TOLK Study (Therapevticheskoe Operativnoe Lechenie Kardiomyopatye)].
    Belenkov IuN; Belianko IE; Gerasimova VV; Dolotov VK; Konstantinov BA; Koroteev AV; Kulagina TIu; Mareev VIu; Rebunenkov GV; Sandrikov VA; Skvortsov AA; Sychev AV; Tereshchenko SN; Khovrin VV
    Kardiologiia; 2005; 45(7):4-9. PubMed ID: 16091653
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of intravenous carvedilol, a new multiple action vasodilatory beta-blocker, in congestive heart failure.
    DasGupta P; Broadhurst P; Lahiri A
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S12-6. PubMed ID: 1721973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute administration of carvedilol is more effective than propranolol plus isosorbide-5-mononitrate in the reduction of portal pressure in patients with viral cirrhosis.
    Lin HC; Yang YY; Hou MC; Huang YT; Lee FY; Lee SD
    Am J Gastroenterol; 2004 Oct; 99(10):1953-8. PubMed ID: 15447755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic administration of carvedilol improves cardiac function in 6-month-old Syrian cardiomyopathic hamsters.
    Cruz N; Arocho L; Rosario L; Crespo MJ
    Pharmacology; 2007; 80(2-3):144-50. PubMed ID: 17534124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local drug delivery.
    Lambert CR; Camenzind E; Robinson K
    Cathet Cardiovasc Diagn; 1997 Jul; 41(3):231. PubMed ID: 9213019
    [No Abstract]   [Full Text] [Related]  

  • 20. Can intravenous beta-blockade predict long-term hemodynamic benefit in chronic congestive heart failure secondary to ischemic heart disease? A comparison of intravenous with oral carvedilol.
    DasGupta P; Lahiri A
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S62-7. PubMed ID: 1378153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.